PAH and Hyperphenylalaninemia: Hyperphenylalaninemias (HPAs) are heterogeneous group of autosomal recessive inborn errors of metabolism characterized by the inability to metabolize phenylalanine (Phe) due to enzyme defects of either phenylalanine hydroxylase (PAH) or its cofactors, resulting in possible consequent neurological damage.1, 2